Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study to Evaluate the Safety and Immunogenicity of a Nontypeable Haemophilus Influenzae Vaccine for Otitis Media

NCT00001605 is registered in ClinicalTrials.gov with National Institute on Deafness and Other Communication Disorders (NIDCD) as lead sponsor.

NCT NCT00001605
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00001605 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study to Evaluate the Safety and Immunogenicity of a Nontypeable Haemophilus Influenzae Vaccine for Otitis Media
Lead sponsor
National Institute on Deafness and Other Communication Disorders (NIDCD)
Phase
Phase 1
Overall status
Completed
Start date
May 31, 1997
Completion date
April 30, 2001
Enrollment
40
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

otitis media